Who’s in the race to develop a COVID-19 vaccine?
At least eight organisations across the world are hurrying to develop and market a vaccine for the coronavirus
The University of Queensland is among the organisations that have been tapped by the Coalition for Epidemic Preparedness Innovations (CEPI) to fast-track a vaccine.
A US company is the first to get to clinical trial, but a Germany biopharmaceutical company is receiving more attention, thanks to US President Donald Trump.
Here’s the latest update on their vaccines:
Moderna/National Institute of Allergy and Infectious Diseases (US): The vaccine moved on to phase-1 testing on Monday when the first of the 45 healthy volunteers (aged 18-55) received the investigational vaccine. The trial will evaluate the safety of different doses of the vaccine and its ability to induce an immune response in participants.
